Archive for PVRIG

A Phase 1 First-Time-in-Human, Open-Label Study of GSK4381562 Administered as Monotherapy and in Combination with Anticancer Agents in Participants with Selected Advanced Solid Tumors

A Phase 1 Study of the Safety and Tolerability of COM902 in Subjects with Advanced Malignancies